Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: February 28, 2023
Reporting Period: Quarter and year ended December 31, 2022
This filing serves as a notification that the company issued a press release announcing its earnings results for the specified periods. The detailed financial data is contained in Exhibit 99.1 and is incorporated by reference.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are located in the unaudited condensed consolidated financial statements referenced in Exhibit 99.1, which are not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that earnings results were announced.
Guidance, Outlook, and Risks
The text does not include specific guidance, outlook, management commentary, risks, contingencies, or unusual items. It states that the press release (Exhibit 99.1) contains these disclosures but does not reproduce them.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for Q4 and FY 2022.
- Verify year-over-year growth rates and margin trends in the unaudited financial statements.
- Check for any forward-looking guidance or updated financial projections included in the press release.
- Confirm the status of debt obligations and liquidity positions as of December 31, 2022.